Artivion Receives FDA Approval for AMDS Hybrid Prosthesis

Artivion has secured FDA premarket approval (PMA) for its AMDS Hybrid Prosthesis, expanding the availability of the device for patients with acute DeBakey Type I aortic dissections accompanied by either clinical or radiographic malperfusion. According to the company, this patient group represents about 60% of all DeBakey Type I aortic dissections, a condition affecting approximately […]

The post Artivion Receives FDA Approval for AMDS Hybrid Prosthesis first appeared on HHM Global | B2B Online Platform & Magazine.